# Top 50 Biotechnology Angel Investors in Europe in June 2026 ## Jonathan Milner - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 31 - Stages: Seed, Series A, Series B - Focus: Biotechnology, Health Care, Medical Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs. ## Nadav Rosenberg - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 5 - Stages: Seed, Pre-Seed, Series A - Focus: Biotechnology, Artificial Intelligence, Software Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France. ## Stefano Bernardi - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 5 - Stages: Seed, Pre-Seed - Focus: Software, Biotechnology, Artificial Intelligence Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech. ## Sake Bosch - Type: Angel - Location: Amsterdam, Noord-Holland, The Netherlands - Relevant deals: 4 - Stages: Seed, Series A, Series B - Focus: Software, E-Commerce, Biotechnology Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering. ## Milad Alucozai - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 4 - Stages: Seed, Series A, Pre-Seed - Focus: Biotechnology, Health Care, Medical Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University. ## Bernard Majoie - Type: Angel - Location: Brussels, Brussels Hoofdstedelijk Gewest, Belgium - Relevant deals: 4 - Stages: Seed, Pre-Seed, Series A - Focus: Biotechnology, Medical, Health Care Bernard Majoie - President @ Fournier-Majoie ## Per Falholt - Type: Angel - Location: Copenhagen, Hovedstaden, Denmark - Relevant deals: 4 - Stages: Pre-Seed, Series A, Seed - Focus: Biotechnology, Robotics, Biopharma A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy. ## Annie Vereecken - Type: Angel - Relevant deals: 4 - Stages: Seed, Series A - Focus: Medical, Biotechnology, Hospital Annie Vereecken ## Charlie Songhurst - Type: Angel - Location: Greater Seattle Area, Washington, United States - Relevant deals: 4 - Stages: Seed, Pre-Seed - Focus: Software, Information Technology, Artificial Intelligence Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics. ## Inaki Berenguer - Type: Angel - Location: New York, New York, United States - Relevant deals: 3 - Stages: Seed, Angel, Pre-Seed - Focus: FinTech, E-Commerce, Financial Services Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics. ## Romain Sautrau - Type: Angel - Location: Paris, Ile-de-France, France - Relevant deals: 3 - Stages: Series A, Seed, Pre-Seed - Focus: Biotechnology, Agriculture, Video Romain Sautrau is a Investment Director at Supernova Invest. Romain attended INSEAD. ## Nicholas Francis - Type: Angel - Location: Copenhagen, Hovedstaden, Denmark - Relevant deals: 3 - Stages: Seed, Series A - Focus: SaaS, Robotics, Software Nicholas Francis is Co-founder at framebunker ## Paul Wicks - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Wellness, E-Commerce Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham. ## Jeff Dean - Type: Angel - Location: Palo Alto, California, United States - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Artificial Intelligence, Information Technology, Software Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award. ## Ian Hogarth - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A, Pre-Seed - Focus: Software, E-Commerce, Artificial Intelligence Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge. ## Andrew Keys - Type: Angel - Relevant deals: 3 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Finance, Blockchain Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland. ## Darrin Disley - Type: Angel - Location: Cambridge, Cambridgeshire, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Big Data Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge. ## David Helgason - Type: Angel - Location: Copenhagen, Hovedstaden, Denmark - Relevant deals: 3 - Stages: Seed, Series A - Focus: Software, Gaming, Information Technology David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen. ## Pierre Drion - Type: Angel - Location: Brussels, Brussels Hoofdstedelijk Gewest, Belgium - Relevant deals: 3 - Stages: Series A, Series B - Focus: Biotechnology, Health Care, Life Science Pierre Drion - CEO @ Petercam ## Taavet Hinrikus - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 3 - Stages: Seed, Series A, Series B - Focus: FinTech, Software, Financial Services Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD. ## Peder Nielsen - Type: Angel - Location: Copenhagen, Hovedstaden, Denmark - Relevant deals: 3 - Stages: Seed, Convertible Note - Focus: Biotechnology, Machine Learning Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund ## Andrea Dusi - Type: Angel - Location: Verona, Veneto, Italy - Relevant deals: 3 - Stages: Seed, Pre-Seed, Series A - Focus: Biotechnology, Health Care, CleanTech Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded Impactscool.He is advisor of dozens oftechnological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018. ## Jude Gomila - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 3 - Stages: Seed, Pre-Seed, Angel - Focus: Software, Biotechnology, Information Technology Jude Gomila is currently CEO and Founder of the startup Golden. ## DrPano Kroko Churchill - Type: Angel - Location: Seattle, Washington, United States - Relevant deals: 3 - Stages: Angel, Series A - Focus: Health Care, Therapeutics, Biotechnology Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com ## Schnidar Harald - Type: Angel - Location: Vienna, Wien, Austria - Relevant deals: 3 - Stages: Seed, Angel, Pre-Seed - Focus: mHealth, Software, Biopharma Entrepreneur, Angel Investor, Scientist and Inventor ## Thomas France - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Blockchain, Information Technology, Financial Services Entrepreneur, Investor ## Sauli Törmälä - Type: Angel - Location: Helsinki, Southern Finland, Finland - Relevant deals: 2 - Stages: Seed - Focus: Life Science, Biotechnology Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu. ## Fiona Pathiraja - Type: Angel - Relevant deals: 2 - Stages: Pre-Seed, Seed, Series A - Focus: Health Care, Biotechnology, Wellness Fiona is Managing Partner at Crista Galli Ventures, an early stage healthtech VC fund based in London and Copenhagen. ## Jim Mellon - Type: Angel - Relevant deals: 2 - Stages: Series A, Seed - Focus: Biotechnology, Food and Beverage, Health Care Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford. ## Xavier Niel - Type: Angel - Location: Paris, Ile-de-France, France - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, Artificial Intelligence, SaaS Xavier Niel is based out of Paris, Ile-de-France and is the Co-Founder and CEO of NJJ Capital. Xavier previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school. ## André-Jacques Auberton-Hervé - Type: Angel - Location: Grenoble, Rhone-Alpes, France - Relevant deals: 2 - Stages: Seed, Series A - Focus: Medical, Biotechnology Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cutâ„¢ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE. ## Edward Lando - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Software, Health Care, Information Technology Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School. ## Detlev Riesner - Type: Angel - Relevant deals: 2 - Stages: Seed - Focus: Biotechnology, Pharmaceutical, Health Care Prof. Riesner has held the Chair of Biophysics at the Heinrich-Heine-University in Düsseldorf, Germany since 1980 and is Director of Technology at the University of Düsseldorf. He received his Ph.D. from the University of Braunschweig, Germany. Prof. Riesner is also a member of the Supervisory Board and a Director of Qiagen N.V., Netherlands. ## Thor Bjorgolfsson - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Series A, Series C - Focus: Big Data, TV, TV Production Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits. ## Rolf Schromgens - Type: Angel - Location: Düsseldorf, Nordrhein-Westfalen, Germany - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Internet, Software, Information Technology Rolf Schromgens - Co-Founder @ leadership.sprouts ## Luc Vauterin - Type: Angel - Relevant deals: 2 - Stages: Seed, Series A - Focus: Life Science, Data Integration, Data Visualization Luc Vauterin - Board Member @ ONTOFORCE ## Jon Oringer - Type: Angel - Location: Miami, Florida, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Software, Information Technology, E-Commerce Jon Oringer is the founder and chairman of Shutterstock. ## Others Others - Type: Angel - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Biotechnology, Software, B2B Others Others ## Aidan Gomez - Type: Angel - Location: Oxford, Arkansas, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Artificial Intelligence, Software, Information Technology Aidan Gomez is a Co-founder & CEO of Cohere. He attended University of Oxford. ## Barbara Castellano - Type: Angel - Location: Milan, Lombardia, Italy - Relevant deals: 2 - Stages: Pre-Seed - Focus: Health Care, Biotechnology, Medical Device Laura Iris Ferro ## Carsten Maschmeyer - Type: Angel - Location: Hanover, Niedersachsen, Germany - Relevant deals: 2 - Stages: Seed, Angel, Series A - Focus: Software, Information Technology, Apps Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success. ## Gilad Engel - Type: Angel - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Hardware, Analytics, Biotechnology Gilad Engel ## Nicolas Douay - Type: Angel - Location: Paris, Ile-de-France, France - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Software, Artificial Intelligence, Information Technology Previously cofounder @ Keldoc - currently early stage investor @ Better Angle ## Vishal Gulati - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Biotechnology, Biopharma, Life Science Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis. ## Ariel Poler - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Angel - Focus: Software, Social Media, Internet Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children. ## Pratima Aiyagari - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Analytics, Cyber Security, SaaS Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains.Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the networkmanagement domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil.Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability. ## Leena Niemistö - Type: Angel - Location: Helsinki, Southern Finland, Finland - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Health Care, Software, E-Commerce Leena Niemistö ## Nico Wittenborn - Type: Angel - Location: New York, New York, United States - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Software, Apps, Wellness Nico Wittenborn is an Investor at Adjacent. ## Paul Forster - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Software, FinTech, Financial Services Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA. ## Tim Dempsey - Type: Angel - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, SaaS, Financial Services Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.